The Zacks Analyst Blog Highlights Verizon Communications, The Southern Company, Blackstone, Utah Medical Products and The Eastern Company

08.04.25 12:21 Uhr

Werte in diesem Artikel
Aktien

115,00 EUR 0,14 EUR 0,12%

80,04 EUR 1,46 EUR 1,86%

19,10 EUR -0,20 EUR -1,04%

45,80 EUR 0,60 EUR 1,33%

38,93 EUR 0,02 EUR 0,05%

Indizes

PKT PKT

40.524,8 PKT 312,1 PKT 0,78%

15.874,6 PKT 232,9 PKT 1,49%

2.619,3 PKT 16,3 PKT 0,63%

5.406,0 PKT 42,6 PKT 0,79%

For Immediate ReleaseChicago, IL – April 8, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Verizon Communications Inc. VZ, The Southern Company SO, Blackstone Inc. BX, Utah Medical Products, Inc. UTMD and The Eastern Company EML.Here are highlights from Monday’s Analyst Blog:Top Research Reports for Verizon, The Southern Co. and BlackstoneThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Verizon Communications Inc., The Southern Company and Blackstone Inc., as well as two micro-cap stocks Utah Medical Products, Inc. and The Eastern Company. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.You can see all of today’s research reports here >>>Ahead of Wall StreetThe daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens and attempts to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.You can read today's AWS here >>> Tariff Saga Starts 2nd Week, Pre-Markets Down Big AgainToday's Featured Research ReportsShares of Verizon have gained +10.1% over the past year against the Zacks Wireless National industry’s gain of +39.8%. The company with one of the most efficient wireless networks in the United States continues to deploy the latest technologies to deliver faster peak data speeds and capacity for customers. Its 5G mobility service offers a premium experience across various industries such as public safety, health care, retail and more.Verizon is offering various mix-and-match pricing in both wireless and home broadband plans, which has led to solid customer additions. The company’s focus on online content delivery, mobile video and online advertising should drive growth.However, fierce competition from other major players and saturation in the wireless market is hurting its profits. High capital expenditures in order to support the launch and continued build-out of its 5G Ultra-Wideband network are straining the margin. Macroeconomic challenges remain a concern.(You can read the full research report on Verizon here >>>)The Southern’s shares have outperformed the Zacks Utility - Electric Power industry over the past year (+31.3% vs. +17.5%). The company, being one of the largest electric utility firms in the U.S., offers a stable, recession-proof business model with predictable earnings, backed by its regulated utility structure and significant capital investments in clean energy, including the Vogtle nuclear units.The Southern is well-positioned to benefit from growing demand, especially from data centers and has planned $63 billion in capital investments to drive future growth. Southern also boasts a long history of reliable dividend payouts.However, the expansion into nuclear energy presents regulatory risks, and climate-related events pose operational challenges. The company’s high leverage and caution around future nuclear investments limit its financial flexibility. Therefore, Southern Company warrants a cautious stance from investors.(You can read the full research report on The Southern here >>>)Shares of Blackstone have declined -0.7% over the past year against the Zacks Financial - Miscellaneous Services industry’s decline of -10.9%. The company has a decent earnings surprise history. Blackstone’s earnings outpaced the Zacks Consensus Estimate in two of the trailing four quarters.A strong revenue mix, global footprint, diversified products, superior position in the alternative investments space and solid total and fee-earning asset under management (AUM) balances are expected to support its financials. Also, robust fundraising ability and significant available capital for deployment will support top-line expansion. The company has a solid balance sheet position, enabling it to address its debt obligations.Nevertheless, elevated consolidated expenses will likely hamper Blackstone’s bottom-line expansion. The low sustainability of its capital distribution activities, given volatile earnings, is worrisome.(You can read the full research report on Blackstone here >>>)Utah Medical Products’ shares have underperformed the Zacks Medical - Products industry over the past year (-20.2% vs. +2.5%). This microcap company with market capitalization of $179.94 million is witnessing profitability under pressure from elevated R&D and SG&A expenses, resulting in a 290 bps year-over-year operating margin decline. Regulatory hurdles pose go-to-market risks. Working capital inefficiencies and high CapEx with limited near-term revenue conversion further weigh on free cash flow and asset utilization.Nevertheless, UTMD benefits from a strong recurring revenue base, zero long-term debt and consistent dividend growth. Its portfolio of high-margin obstetric and gynecological devices enjoys global clinical trust, enabling resilient pricing and cash flow.Strategic exposure to the growing women’s and neonatal health market provides insulation from broader healthcare cyclicality. UTMD's global reach (100+ countries) diversifies revenues and reduces regional risk. Operationally, its in-house manufacturing drives margin stability and supply chain control.(You can read the full research report on Utah Medical Products here >>>)Shares of The Eastern have underperformed the Zacks Security and Safety Services industry over the past year (-27.2% vs. -9.7%). This microcap company with market capitalization of $145.2 million is having SG&A rose 7.9% due to restructuring costs, and Big 3’s packaging backlog declined, signaling potential demand softness. Eastern remains highly exposed to Class 8 OEM cycles, and a reduction in product development spending raises concerns about future innovation capacity.Nevertheless, Eastern Company is advancing its market leadership in Class 8 truck components through Velvac’s new mirror platform, which has driven significant backlog growth and captured OEM share. Its robust aftermarket business offers resilience beyond production cycles.FY2024 net income rose 12% to $13.2 million, with adjusted income at $14.2 million and leverage down to 1.23X. Strong cash generation supported $2.7 million in dividends and share repurchases. A diversified manufacturing base across the United States, Mexico, and China enhances supply chain flexibility and customer responsiveness.(You can read the full research report on The Eastern here >>>)Why Haven't You Looked at Zacks' Top Stocks?Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.Today you can access their live picks without cost or obligation.See Stocks Free >>Zacks Investment Research800-767-3771 ext. 9339support@zacks.comhttps://www.zacks.comPast performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Southern Company (The) (SO): Free Stock Analysis Report Blackstone Inc. (BX): Free Stock Analysis Report Verizon Communications Inc. (VZ): Free Stock Analysis Report Utah Medical Products, Inc. (UTMD): Get Free Report Eastern Company (The) (EML): Get Free ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Blackstone und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Blackstone

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Blackstone

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Verizon Inc.

Wer­bung

Analysen zu Verizon Inc.

DatumRatingAnalyst
05.11.2020Verizon overweightJP Morgan Chase & Co.
24.04.2019Verizon Sector PerformRBC Capital Markets
23.04.2019Verizon buyGoldman Sachs Group Inc.
04.09.2018Verizon Equal WeightBarclays Capital
11.05.2018Verizon overweightJP Morgan Chase & Co.
DatumRatingAnalyst
05.11.2020Verizon overweightJP Morgan Chase & Co.
23.04.2019Verizon buyGoldman Sachs Group Inc.
11.05.2018Verizon overweightJP Morgan Chase & Co.
23.04.2018Verizon OverweightBarclays Capital
22.01.2018Verizon Sector OutperformScotia Howard Weil
DatumRatingAnalyst
24.04.2019Verizon Sector PerformRBC Capital Markets
04.09.2018Verizon Equal WeightBarclays Capital
31.07.2017Verizon Sector PerformRBC Capital Markets
14.07.2017Verizon Equal WeightBarclays Capital
21.04.2017Verizon HoldArgus Research Company
DatumRatingAnalyst
18.08.2009Verizon Communications neues KurszielSanford C. Bernstein and Co., Inc.
06.01.2009Verizon Communications DowngradeSanford C. Bernstein and Co., Inc.
24.04.2007Verizon Communications underweightPrudential Financial
21.11.2006Verizon underweightPrudential Financial
21.11.2006Verizon Communications underweightPrudential Financial

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Verizon Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen